Target intelligence / Profile preview

Uromodulin-like 1 (UMODL1)

Target
UMODL1
Molecular classification
Extracellular matrix protein, Membrane-bound protein, EGF-like domain protein, WAP-domain protein, FNIII-domain protein
01

Overview

Uromodulin-like 1 (UMODL1), also known as olfactorin, is a calcium-dependent membrane-bound extracellular matrix protein carrying EGF-like, WAP, and FNIII domains[2][3][4]. It is expressed during the development of the olfactory system and along the migratory route of hypothalamic gonadotropin-releasing hormone (GnRH) neurons[2][4]. UMODL1 shares functional and structural similarity with anosmin-1 and is implicated in axonal guidance, neuronal migration, and proper connectivity of GnRH and olfactory neurons. Its deficiency in animal models leads to abnormal development of these neurons, reproductive defects, and altered immune response[2][3][4]. Location on chromosome 21 suggests potential linkage to Down syndrome phenotypes, though its precise disease mechanisms in humans remain under study[2]. UMODL1 is under experimental investigation as a candidate gene in Kallmann syndrome, with no approved drugs targeting it and unknown baseline safety profiles for clinical exploitation.

Other names
Uromodulin-like 1UMODL1Olfactorinolfactorinuromodulin-like 1
02

Biological functions

Neuronal migration and development (notably GnRH neurons)Axonal guidance (olfactory axons)Immune system response (CD4+ T cell proliferation in mice)Follicular development and depletion (ovarian function)
03

Disease associations

Neurodevelopmental disorder (Kallmann syndrome)Reproductive defects (potential involvement in hypogonadism and abnormal GnRH neuron migration)Possible relevance in Down syndrome (gene location)Female reproductive system dysfunction (premature ovarian failure observed in mice)Immune dysregulation
04

Safety considerations

Potential reproductive and neurodevelopmental side effects if modulated, based on animal modelsUnknown safety profile for clinical manipulation

Beyond the preview

Go deeper on Uromodulin-like 1 (UMODL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uromodulin-like 1 (UMODL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call